Trademark applications and grants for Spectrum Pharmaceuticals, Inc.. Spectrum Pharmaceuticals, Inc. has 27 trademark applications. The latest application filed is for "ACCESS4ME"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 157 Technology Drive Irvine, CALIFORNIA UNITED STATES 92618 |
Patent Application | Date |
---|---|
Poziotinib Combination with VEGFR2 Inhibitors and Methods of Use Thereof 20220296598 - 17/637304 Reddy; Guru | 2022-09-22 |
Methods of Treatment Using G-CSF Protein Complex 20220153799 - 17/586872 Bhat; Gajanan ;   et al. | 2022-05-19 |
KITS AND METHODS FOR TREATING CANCERS 20220040180 - 17/275290 Reddy; Guru | 2022-02-10 |
METHODS OF TREATING CHEMOTHERAPY INDUCED NEUTROPENIA USING FIXED DOSES OF G-CSF PROTEIN COMPLEX 20220016212 - 17/374302 Barrett; John A. ;   et al. | 2022-01-20 |
NOVEL QUINAZOLINE EGFR INHIBITORS 20210353627 - 17/278397 Chaturvedula; Prasad V. | 2021-11-18 |
NCAGE Code | 5BDW2 | SPECTRUM PHARMACEUTICALS, INC. |
CAGE Code | 5BDW2 | SPECTRUM PHARMACEUTICALS, INC. |
S.A.M. Registration | 5BDW2 [790888002] | SPECTRUM PHARMACEUTICALS, INC. |
SEC | 0000831547 | SPECTRUM PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.